Systematic review of enhanced recovery after surgery in perioperative management of pancreaticoduodenectomy: a meta-analysis of randomized controlled trials and non-randomized controlled trials

Q4 Nursing

中华临床营养杂志 Pub Date : 2018-02-28 DOI:10.3760/CMA.J.ISSN.1674-635X.2018.01.001

Tao Zhang, Liang Yu, Shunli Fan, Fei Pan, Dong Zhang, Q. He

{"title":"Systematic review of enhanced recovery after surgery in perioperative management of pancreaticoduodenectomy: a meta-analysis of randomized controlled trials and non-randomized controlled trials","authors":"Tao Zhang, Liang Yu, Shunli Fan, Fei Pan, Dong Zhang, Q. He","doi":"10.3760/CMA.J.ISSN.1674-635X.2018.01.001","DOIUrl":null,"url":null,"abstract":"Objective \nTo systematically review the safety and efficacy of enhanced recovery after surgery (ERAS) in perioperative management of pancreaticoduodenectomy. \n \n \nMethods \nA search was performed in databases (including PubMed, EMASE, Cochrane library, Sinomed, Wangfang, VIP, and CNKI) for randomized controlled trials (RCTs) and non-randomized controlled trials (NRCTs) up to September 2016 on use of ERAS in patients undergoing pancreaticoduodenectomy. After quality evaluation and data extraction, meta-analysis was performed using RevMan 5.3. \n \n \nResults \nFour RCTs and Twelve NRCTs involving a total of 2 828 patients were included. 1 401 patients were in the ERAS group, and 1 427 in the control group. Meta-analysis results showed that compared with the control group, the ERAS group had shorter length of hospital stay (SMD=-0.36, 95% CI=-0.44--0.28, P 0.05). \n \n \nConclusion \nIt is reasonably safe and efficacious to adopt ERAS in periopetative management of patients undergoing pancreaticoduodenectomy. \n \n \nKey words: \nEnhanced recovery after surgery; Pancreaticoduodenectomy; Perioperative; Meta-analysis","PeriodicalId":9877,"journal":{"name":"中华临床营养杂志","volume":"26 1","pages":"1-8"},"PeriodicalIF":0.0000,"publicationDate":"2018-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中华临床营养杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.1674-635X.2018.01.001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Nursing","Score":null,"Total":0}

引用次数: 1

Abstract

Objective To systematically review the safety and efficacy of enhanced recovery after surgery (ERAS) in perioperative management of pancreaticoduodenectomy. Methods A search was performed in databases (including PubMed, EMASE, Cochrane library, Sinomed, Wangfang, VIP, and CNKI) for randomized controlled trials (RCTs) and non-randomized controlled trials (NRCTs) up to September 2016 on use of ERAS in patients undergoing pancreaticoduodenectomy. After quality evaluation and data extraction, meta-analysis was performed using RevMan 5.3. Results Four RCTs and Twelve NRCTs involving a total of 2 828 patients were included. 1 401 patients were in the ERAS group, and 1 427 in the control group. Meta-analysis results showed that compared with the control group, the ERAS group had shorter length of hospital stay (SMD=-0.36, 95% CI=-0.44--0.28, P 0.05). Conclusion It is reasonably safe and efficacious to adopt ERAS in periopetative management of patients undergoing pancreaticoduodenectomy. Key words: Enhanced recovery after surgery; Pancreaticoduodenectomy; Perioperative; Meta-analysis

查看原文本刊更多论文

胰十二指肠切除术围手术期术后恢复增强的系统评价：随机对照试验和非随机对照试验的荟萃分析

目的系统评价增强术后恢复（ERAS）在胰十二指肠切除术围手术期管理中的安全性和有效性。方法检索截至2016年9月的数据库（包括PubMed、EMASE、Cochrane library、Sinomed、Wangfang、VIP和CNKI）中关于ERAS在胰十二指肠切除术患者中使用的随机对照试验（RCT）和非随机对照试验。在质量评估和数据提取后，使用RevMan 5.3进行荟萃分析。结果纳入4例随机对照试验和12例NRCT，共2288例。ERAS组为1401例，对照组为1427例。荟萃分析结果显示，与对照组相比，ERAS组的住院时间更短（SMD=-0.36，95%CI=-0.44--0.28，P 0.05）。关键词：术后恢复增强；胰十二指肠切除术；围手术期；Meta分析

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

中华临床营养杂志 Nursing-Nutrition and Dietetics

CiteScore

0.20

自引率

0.00%

发文量

2282

期刊介绍： The Chinese Journal of Clinical Nutrition was founded in 1993. It is the first professional academic journal (bimonthly) in my country co-sponsored by the Chinese Medical Association and the Chinese Academy of Medical Sciences to disseminate information on clinical nutrition support, nutrient metabolism, the impact of nutrition support on outcomes and "cost-effectiveness", as well as translational medicine and nutrition research. It is also a professional journal of the Chinese Medical Association's Parenteral and Enteral Nutrition Branch. The purpose of the Chinese Journal of Clinical Nutrition is to promote the rapid dissemination of knowledge on nutrient metabolism and the rational application of parenteral and enteral nutrition, focusing on the combination of multidisciplinary and multi-regional field investigations and clinical research. It mainly reports on nutritional risk screening related to the indications of parenteral and enteral nutrition support, "cost-effectiveness" research on nutritional drugs, consensus on clinical nutrition, guidelines, expert reviews, randomized controlled studies, cohort studies, glycoprotein and other nutrient metabolism research, systematic evaluation of clinical research, evidence-based case reports, special reviews, case reports and clinical experience exchanges, etc., and has a special column on new technologies related to the field of clinical nutrition and their clinical applications.